Product: GeneStrat
-
Changes in ctDNA levels as an early indicator of outcomes in advanced NSCLC treated with TKI: Initial findings from a retrospective aggregate analysis of 8 clinical trials
-
Turnaround Time and Variant Prevalence of a Blood-based KRAS Test in patients with NSCLC
-
Validation of the EGFR Uncommon Variants Multiplex ddPCR Assay for Blood-Based Testing in NSCLC
-
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
-
Highly Multiplexed Diagnostic Test for the Detection of Extended EGFR del19 Variants in Patients with NSCLC
-
Faster Turnaround Spurs Clinical Adoption of Liquid Biopsy Tests for Treating Non-Small Cell Lung Cancer
-
Development and Clinical Utility of a Blood-Based Test Service for the Rapid Identification of Actionable Mutations in Non-Small Cell Lung Carcinoma.
-
Early feasibility and development of multiplexed, single-reaction assay for ALK, ROS1 and RET novel ddPCR fusions
-
Utility of a targeted NSCLC genomic test for cfDNA variants in the community setting
-
Blood-Based Mutation Testing in Non-small Cell Lung Carcinoma Patients Supports Individualized and Optimal Treatment